Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BMGL NYSE:CCM NASDAQ:MRAI NASDAQ:NIVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$7.03+1.4%$7.45$4.60▼$54.60$10.84M0.19150,328 shs8,001 shsCCMConcord Medical Services$4.65+1.9%$4.63$3.18▼$10.77$19.80M-0.9943,740 shs41,926 shsMRAIMarpai$0.72+11.5%$0.42$0.22▼$1.78$19.03M4.9460,833 shs728 shsNIVFNewGenIvf Group$0.63-3.0%$1.18$0.47▼$372.00$6.54M-0.0710.63 million shs407,769 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group-6.50%-8.33%-3.27%-7.89%-76.04%CCMConcord Medical Services-14.29%-2.77%-7.13%+21.47%-21.39%MRAIMarpai-7.47%-1.51%+129.00%+42.17%-49.11%NIVFNewGenIvf Group-3.36%-7.23%-36.33%-67.69%-99.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$7.03+1.4%$7.45$4.60▼$54.60$10.84M0.19150,328 shs8,001 shsCCMConcord Medical Services$4.65+1.9%$4.63$3.18▼$10.77$19.80M-0.9943,740 shs41,926 shsMRAIMarpai$0.72+11.5%$0.42$0.22▼$1.78$19.03M4.9460,833 shs728 shsNIVFNewGenIvf Group$0.63-3.0%$1.18$0.47▼$372.00$6.54M-0.0710.63 million shs407,769 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group-6.50%-8.33%-3.27%-7.89%-76.04%CCMConcord Medical Services-14.29%-2.77%-7.13%+21.47%-21.39%MRAIMarpai-7.47%-1.51%+129.00%+42.17%-49.11%NIVFNewGenIvf Group-3.36%-7.23%-36.33%-67.69%-99.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMGLBasel Medical Group 1.00SellN/AN/ACCMConcord Medical Services 1.00SellN/AN/AMRAIMarpai 0.00N/AN/AN/ANIVFNewGenIvf Group 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest NIVF, CCM, MRAI, and BMGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/15/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/29/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/26/2026CCMConcord Medical Services Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/8/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/27/2026NIVFNewGenIvf Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/24/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMGLBasel Medical Group$8.90M1.23N/AN/A$2.44 per share2.88CCMConcord Medical Services$65.85M0.31$1.90 per share2.45$60.94 per share0.08MRAIMarpai$34.87M0.55N/AN/A($1.72) per share-0.42NIVFNewGenIvf Group$4.73M1.34$31.50 per share0.02$105.78 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMGLBasel Medical Group-$9.50MN/AN/AN/AN/AN/AN/AN/AN/ACCMConcord Medical Services-$13.27MN/AN/AN/AN/AN/AN/AN/AN/AMRAIMarpai-$28.75M-$0.87N/AN/AN/A-85.70%N/A-100.23%8/12/2026 (Estimated)NIVFNewGenIvf Group$9.88MN/AN/A0.07N/AN/AN/AN/A6/30/2026 (Estimated)Latest NIVF, CCM, MRAI, and BMGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/30/2026N/ANIVFNewGenIvf Group$185.40N/AN/AN/A$2.87 millionN/A4/29/2026Q4 2025CCMConcord Medical ServicesN/A-$1.08N/A-$1.08N/AN/A3/31/2026Q4 2025NIVFNewGenIvf GroupN/A-$287.24N/A-$287.24N/A$1.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBMGLBasel Medical GroupN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/AMRAIMarpaiN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMGLBasel Medical GroupN/AN/AN/ACCMConcord Medical Services1.330.480.46MRAIMarpaiN/A0.820.82NIVFNewGenIvf Group0.163.122.98Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMGLBasel Medical GroupN/ACCMConcord Medical ServicesN/AMRAIMarpai49.75%NIVFNewGenIvf Group66.24%Insider OwnershipCompanyInsider OwnershipBMGLBasel Medical GroupN/ACCMConcord Medical Services46.50%MRAIMarpai46.10%NIVFNewGenIvf Group31.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMGLBasel Medical Group361.56 millionN/AN/ACCMConcord Medical Services9704.34 million2.32 millionNot OptionableMRAIMarpai15026.61 million5.61 millionNo DataNIVFNewGenIvf GroupN/A10.07 million6.87 millionN/ANIVF, CCM, MRAI, and BMGL HeadlinesRecent News About These CompaniesNewGenIvf Group (NIVF) Expected to Release Earnings on TuesdayJune 23 at 1:26 AM | americanbankingnews.comNewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market CapitalizationJune 22 at 8:30 AM | globenewswire.comNewGenIVF Group Limited: NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million InvestedJune 18, 2026 | finanznachrichten.deNewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million InvestedJune 18, 2026 | globenewswire.comNewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital StructureJune 16, 2026 | globenewswire.comNewGenIvf Group Adds Four Independent Directors to Board in June 2026June 11, 2026 | tipranks.comNewGen Adds to K25.ai Investment as AI Prediction Market Push DeepensJune 6, 2026 | finance.yahoo.comNewGenIVF Deepens Commitment to K25.ai with Additional $4 Million InvestmentJune 4, 2026 | msn.comNewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury StrategyJune 4, 2026 | globenewswire.comNewGenIvf Group (NASDAQ:NIVF) Major Shareholder Sells $68,253.60 in StockMay 29, 2026 | insidertrades.comNewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy CheungMay 28, 2026 | globenewswire.comFinancial Lp Hrt Purchases 27,993 Shares of NewGenIvf Group (NASDAQ:NIVF) StockMay 28, 2026 | insidertrades.comNewGenIVF Invests in Singapore AI Prediction Platform K25.aiMay 25, 2026 | crowdfundinsider.comCNIVF Management Continues Aggressive AI ExpansionMay 22, 2026 | msn.comWhy Is NewGenIvf Group Stock Falling On Friday?May 22, 2026 | benzinga.comK25.ai, Led by Tech Veteran Andy Cheung, Eyes Public Listing as World's First Prediction Market After $100M Valuation Investment from Nasdaq-Listed Strategic PartnerMay 21, 2026 | prnewswire.comNewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million ValuationMay 21, 2026 | globenewswire.comNewGenIVF Group Limited: NewGen Provides Update on Fiscal Year 2025 Results and Strategic ProgressMay 4, 2026 | finanznachrichten.deNewGen Provides Update on Fiscal Year 2025 Results and Strategic ProgressMay 4, 2026 | globenewswire.comNewGenIvf Group Limited Class A Ordinary Shares (NIVF) ChartsApril 5, 2026 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNIVF, CCM, MRAI, and BMGL Company DescriptionsBasel Medical Group NASDAQ:BMGL$7.03 +0.10 (+1.44%) Closing price 04:00 PM EasternExtended Trading$6.70 -0.33 (-4.69%) As of 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.Concord Medical Services NYSE:CCM$4.65 +0.09 (+1.89%) Closing price 03:54 PM EasternExtended Trading$4.73 +0.08 (+1.81%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Marpai NASDAQ:MRAI$0.72 +0.07 (+11.53%) As of 11:52 AM EasternMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.NewGenIvf Group NASDAQ:NIVF$0.63 -0.02 (-2.99%) Closing price 04:00 PM EasternExtended Trading$0.60 -0.04 (-5.56%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why KB Home Could Reward Patient Investors Later Tesla's New NHTSA Probe Lands at the Worst Possible Time Meta's Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time ASML’s Chip Dominance Runs Into New Silicon Boundaries Frozen Assets: How Super Micro Puts AI Heat on Ice The SpaceX Sell-Off May Be More Than a Market Overreaction Why These South Korea-Focused ETFs Have More Than Doubled in 2026 Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.